ECHA Finds 22 Labs Ready for One-Generation Reproductive Toxicity Studies

ECHA performed a similar study in 2012 and now reports that global laboratory capacity to conduct the studies has increased. The latest study was triggered by the recent change in the REACH information requirements.

The European Chemicals Agency (ECHA), after commissioning a study on global laboratory capacities to conduct extended one-generation reproductive toxicity studies, known as EOGRTS, announced Jan. 13 that it has identified 22 laboratories capable of conducting those studies. ECHA estimates that for 2016, 2018, and 2020, these laboratories could deliver the following ranges of EOGRTS with basic study design: 88-114, 94-122 and 101-131 respectively. Regarding full study designs, the ranges are 44-57, 49-63 and 61-79 for the respective years.

ECHA performed a similar study in 2012 and now reports that global laboratory capacity to conduct the studies has increased. The latest study was triggered by the recent change in the REACH information requirements, where EOGRTS replaced the previous two-generation reproductive toxicity study.

The report says ECHA's survey was completed in eight countries: India, the United Kingdom, the Netherlands, United States, Poland, Germany, Italy, and also France.

Adopted by the OECD Test Guidelines Programme in July 2011, the studies potentially generate more toxicological information from fewer animals than the two-generation reproductive toxicity study, according to the report. It says the "increased sophistication, extent and duration of F1 offspring assessments are believed to allow adequate prediction on the reproductive toxicity without the need to assess the effects on functional fertility and reproductive performance of the F1 animals. The EOGRTS include F1 neurotoxicity and immunotoxicity assessments and test parental fertility and reproductive function, in addition to pre- and post-natal effects.

Product Showcase

  • InteliSwab® COVID-19 Rapid Test

    InteliSwab® COVID-19 Rapid Test

    The InteliSwab® COVID-19 Rapid Test from OraSure is a remarkably simple, and easy to use, at-home COVID-19 rapid antigen test. InteliSwab puts the power of rapid results right in your hands. Anytime, anywhere, just swab, swirl and see results in minutes. InteliSwab has been tested against variants of concern and successfully detects Omicron subvariants. By testing frequently in the workplace, you can help prevent disruption and strengthen occupational health. Try InteliSwab today and get your free sample kit here: info.inteliswab.com/2023-paidmedia-ohs-productshowcase-inteliswab-june 3

  • Make selection & use of SRLs simpler with the new V-SHOCK line

    Make selection & use of SRLs simpler with the new V-SHOCK line

    The new MSA V-SHOCK EDGE Cable SRLs and Web PFLs for Leading Edge use are designed for simplicity and hassle-free safety. V-SHOCK EDGE solutions help make PPE selection on the jobsite quick and easy with color-coded housings, clear icons on labels, and clearance charts in the label pack. 3

  • STUDSON SHK-1 Full-Brim

    STUDSON SHK-1 Full-Brim

    STUDSON’s latest SHK-1 Full-Brim is the first and only Full-Brim Type-2 safety helmet on the market today. With a history of pursuing the most cutting-edge solutions in industrial head safety, STUDSON is proud to announce its latest innovation, the all-new Full Brim Type-2 safety helmet. Like every STUDSON safety helmet, its imbedded with the latest cutting-edge technologies. Koroyd provides industry leading impact absorption in protecting the head and neck while twICEme® technology delivers vital information when it matters most. STUDSON’s full-brim Type-2 helmet is simply the most innovative helmet on the market today. Visit us at ASSP booth #413. 3

Featured